Less Ads, More Data, More Tools Register for FREE

Pin to quick picksShield Thera Share News (STX)

Share Price Information for Shield Thera (STX)

Share Price is delayed by 15 minutes
Get Live Data
5.75    -0.10 (-1.71%)
Bid:
5.70
Ask:
5.80
Spread: 0.10 (1.754%)
Market Cap: £61.50m
STX Live PriceLast checked at - London Stock Exchange

Intraday Shield Thera Share Chart

Shield Thera News

LONDON MARKET CLOSE: FTSE 100 takes hit ahead of FOMC minutes
21 Feb 2024

LONDON MARKET CLOSE: FTSE 100 takes hit ahead of FOMC minutes

(Alliance News) - Stock prices in London closed lower on Wednesday, as investors anxiously look ahead to this evening's Federal Open Market Committee ...

Shield Therapeutics sinks as strong performance marred by data issues
21 Feb 2024

Shield Therapeutics sinks as strong performance marred by data issues

(Alliance News) - Shield Therapeutics PLC on Wednesday said that it was expecting stellar results for 2023, but this success was overshadowed by a mis...

IN BRIEF: Shield Therapeutics hires former Akili leader as new CFO
9 Jan 2024

IN BRIEF: Shield Therapeutics hires former Akili leader as new CFO

Shield Therapeutics PLC - Commercial-stage pharmaceutical company focused on iron deficiency product Accrufer - Hires Santosh Shanbhag as chief financ...

TRADING UPDATES: Comptoir opens restaurant; Intercede wins contract
7 Dec 2023

TRADING UPDATES: Comptoir opens restaurant; Intercede wins contract

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Shield Therapeutics reports strong US progress
7 Dec 2023

Shield Therapeutics reports strong US progress

(Sharecast News) - Iron deficiency-focussed pharmaceuticals company Shield Therapeutics announced significant achievements in the US commercialisation...

IN BRIEF: Shield Therapeutics Chief Financial Officer Rudolf to leave
12 Oct 2023

IN BRIEF: Shield Therapeutics Chief Financial Officer Rudolf to leave

Shield Therapeutics PLC - commercial-stage pharmaceutical company focusing on its iron deficiency product Accrufer - Chief Financial Officer Hans-Pete...

AIM WINNERS & LOSERS: Windward sees high contracting activity levels
12 Oct 2023

AIM WINNERS & LOSERS: Windward sees high contracting activity levels

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Thursday.